01708nam 2200397Ia 450 991069664860332120080610093010.0(CKB)5470000002380376(OCoLC)231620845(EXLCZ)99547000000238037620080610d2008 ua 0engurmn|||||||||txtrdacontentcrdamediacrrdacarrierPrescription drugs[electronic resource] trends in FDA's oversight of direct-to-consumer advertising : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives /statement of Marcia Crosse[Washington, D.C.] :U.S. Govt. Accountability Office,[2008]15 pages digital, PDF fileTestimony ;GAO-08-758 TTitle from title screen (viewed on June 3, 2008)."For release ... May 8, 2008."Paper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.Includes bibliographical references.Prescription drugs Direct-to-consumer prescription drug advertisingUnited StatesDirect-to-consumer prescription drug advertisingCrosse Marcia1380679United States.Congress.House.Committee on Energy and Commerce.Subcommittee on Oversight and Investigations.United States.Government Accountability Office.GPOGPOBOOK9910696648603321Prescription drugs3427483UNINA